Terns Pharmaceuticals
Why Robinhood?
You can watch TERN and buy or sell other stocks, ETFs, and their options commission-free!About TERN
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program.
TERN Key Statistics
Stock Snapshot
With a market cap of 5.95B, Terns Pharmaceuticals(TERN) trades at $52.95. The stock has a price-to-earnings ratio of -51.28.
On 2026-07-25, Terns Pharmaceuticals(TERN) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 909.82K.
The stock's 52-week range extends from a low of $2.75 to a high of $53.19.
The stock's 52-week range extends from a low of $2.75 to a high of $53.19.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.